▶ 調査レポート

幹細胞治療のグローバル市場インサイト・予測(~2028年)

• 英文タイトル:Global Stem Cell Therapy Market Insights and Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。幹細胞治療のグローバル市場インサイト・予測(~2028年) / Global Stem Cell Therapy Market Insights and Forecast to 2028 / QY2203B08258資料のイメージです。• レポートコード:QY2203B08258
• 出版社/出版日:QYResearch / 2022年3月
• レポート形態:英文、PDF、95ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥686,000 (USD4,900)▷ お問い合わせ
  Multi User¥1,029,000 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,372,000 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界の幹細胞治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に幹細胞治療の世界市場のxxx%を占める「自家製」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「筋骨格系疾患」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
中国の幹細胞治療の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの幹細胞治療市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパの幹細胞治療市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

幹細胞治療のグローバル主要メーカーには、Osiris Therapeutics、NuVasive、Chiesi Pharmaceuticals、JCR Pharmaceutical、Pharmicell、Medi-post、Anterogen、Molmed、Takeda (TiGenix)などがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

幹細胞治療市場は、種類と用途によって区分されます。世界の幹細胞治療市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
自家製、同種異系

【用途別セグメント】
筋骨格系疾患、創傷・外傷、角膜、循環器系疾患、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- 幹細胞治療製品概要
- 種類別市場(自家製、同種異系)
- 用途別市場(筋骨格系疾患、創傷・外傷、角膜、循環器系疾患、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界の幹細胞治療販売量予測2017-2028
- 世界の幹細胞治療売上予測2017-2028
- 幹細胞治療の地域別販売量
- 幹細胞治療の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別幹細胞治療販売量
- 主要メーカー別幹細胞治療売上
- 主要メーカー別幹細胞治療価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(自家製、同種異系)
- 幹細胞治療の種類別販売量
- 幹細胞治療の種類別売上
- 幹細胞治療の種類別価格
・用途別市場規模(筋骨格系疾患、創傷・外傷、角膜、循環器系疾患、その他)
- 幹細胞治療の用途別販売量
- 幹細胞治療の用途別売上
- 幹細胞治療の用途別価格
・北米市場
- 北米の幹細胞治療市場規模(種類別、用途別)
- 主要国別の幹細胞治療市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパの幹細胞治療市場規模(種類別、用途別)
- 主要国別の幹細胞治療市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋の幹細胞治療市場規模(種類別、用途別)
- 主要国別の幹細胞治療市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米の幹細胞治療市場規模(種類別、用途別)
- 主要国別の幹細胞治療市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカの幹細胞治療市場規模(種類別、用途別)
- 主要国別の幹細胞治療市場規模(トルコ、サウジアラビア)
・企業情報
Osiris Therapeutics、NuVasive、Chiesi Pharmaceuticals、JCR Pharmaceutical、Pharmicell、Medi-post、Anterogen、Molmed、Takeda (TiGenix)
・産業チェーン及び販売チャネル分析
- 幹細胞治療の産業チェーン分析
- 幹細胞治療の原材料
- 幹細胞治療の生産プロセス
- 幹細胞治療の販売及びマーケティング
- 幹細胞治療の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 幹細胞治療の産業動向
- 幹細胞治療のマーケットドライバー
- 幹細胞治療の課題
- 幹細胞治療の阻害要因
・主な調査結果

Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.
Market Analysis and Insights: Global Stem Cell Therapy Market
The global Stem Cell Therapy market size is projected to reach US$ 1711.9 million by 2028, from US$ 479.5 million in 2021, at a CAGR of 19.7% during 2022-2028.
North America is the largest Stem Cell Therapy market with about 65% market share. Europe is follower, accounting for about 16% market share.
The key players are Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, JCR Pharmaceutical, Pharmicell, Medi-post, Anterogen, Molmed, Takeda (TiGenix) etc. Top 3 companies occupied about 38% market share.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Stem Cell Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Stem Cell Therapy market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Stem Cell Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Stem Cell Therapy market.
Global Stem Cell Therapy Scope and Market Size
Stem Cell Therapy market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Stem Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Autologous
Allogeneic
Segment by Application
Musculoskeletal Disorder
Wounds & Injuries
Cornea
Cardiovascular Diseases
Others
By Company
Osiris Therapeutics
NuVasive
Chiesi Pharmaceuticals
JCR Pharmaceutical
Pharmicell
Medi-post
Anterogen
Molmed
Takeda (TiGenix)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stem Cell Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Autologous
1.2.3 Allogeneic
1.3 Market by Application
1.3.1 Global Stem Cell Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Musculoskeletal Disorder
1.3.3 Wounds & Injuries
1.3.4 Cornea
1.3.5 Cardiovascular Diseases
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Stem Cell Therapy Market Perspective (2017-2028)
2.2 Stem Cell Therapy Growth Trends by Region
2.2.1 Stem Cell Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Stem Cell Therapy Historic Market Size by Region (2017-2022)
2.2.3 Stem Cell Therapy Forecasted Market Size by Region (2023-2028)
2.3 Stem Cell Therapy Market Dynamics
2.3.1 Stem Cell Therapy Industry Trends
2.3.2 Stem Cell Therapy Market Drivers
2.3.3 Stem Cell Therapy Market Challenges
2.3.4 Stem Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Stem Cell Therapy Players by Revenue
3.1.1 Global Top Stem Cell Therapy Players by Revenue (2017-2022)
3.1.2 Global Stem Cell Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Stem Cell Therapy Revenue
3.4 Global Stem Cell Therapy Market Concentration Ratio
3.4.1 Global Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stem Cell Therapy Revenue in 2021
3.5 Stem Cell Therapy Key Players Head office and Area Served
3.6 Key Players Stem Cell Therapy Product Solution and Service
3.7 Date of Enter into Stem Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Stem Cell Therapy Breakdown Data by Type
4.1 Global Stem Cell Therapy Historic Market Size by Type (2017-2022)
4.2 Global Stem Cell Therapy Forecasted Market Size by Type (2023-2028)
5 Stem Cell Therapy Breakdown Data by Application
5.1 Global Stem Cell Therapy Historic Market Size by Application (2017-2022)
5.2 Global Stem Cell Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Stem Cell Therapy Market Size (2017-2028)
6.2 North America Stem Cell Therapy Market Size by Type
6.2.1 North America Stem Cell Therapy Market Size by Type (2017-2022)
6.2.2 North America Stem Cell Therapy Market Size by Type (2023-2028)
6.2.3 North America Stem Cell Therapy Market Share by Type (2017-2028)
6.3 North America Stem Cell Therapy Market Size by Application
6.3.1 North America Stem Cell Therapy Market Size by Application (2017-2022)
6.3.2 North America Stem Cell Therapy Market Size by Application (2023-2028)
6.3.3 North America Stem Cell Therapy Market Share by Application (2017-2028)
6.4 North America Stem Cell Therapy Market Size by Country
6.4.1 North America Stem Cell Therapy Market Size by Country (2017-2022)
6.4.2 North America Stem Cell Therapy Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Stem Cell Therapy Market Size (2017-2028)
7.2 Europe Stem Cell Therapy Market Size by Type
7.2.1 Europe Stem Cell Therapy Market Size by Type (2017-2022)
7.2.2 Europe Stem Cell Therapy Market Size by Type (2023-2028)
7.2.3 Europe Stem Cell Therapy Market Share by Type (2017-2028)
7.3 Europe Stem Cell Therapy Market Size by Application
7.3.1 Europe Stem Cell Therapy Market Size by Application (2017-2022)
7.3.2 Europe Stem Cell Therapy Market Size by Application (2023-2028)
7.3.3 Europe Stem Cell Therapy Market Share by Application (2017-2028)
7.4 Europe Stem Cell Therapy Market Size by Country
7.4.1 Europe Stem Cell Therapy Market Size by Country (2017-2022)
7.4.2 Europe Stem Cell Therapy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Stem Cell Therapy Market Size (2017-2028)
8.2 Asia-Pacific Stem Cell Therapy Market Size by Type
8.2.1 Asia-Pacific Stem Cell Therapy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Stem Cell Therapy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Stem Cell Therapy Market Share by Type (2017-2028)
8.3 Asia-Pacific Stem Cell Therapy Market Size by Application
8.3.1 Asia-Pacific Stem Cell Therapy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Stem Cell Therapy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Stem Cell Therapy Market Share by Application (2017-2028)
8.4 Asia-Pacific Stem Cell Therapy Market Size by Region
8.4.1 Asia-Pacific Stem Cell Therapy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Stem Cell Therapy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Stem Cell Therapy Market Size (2017-2028)
9.2 Latin America Stem Cell Therapy Market Size by Type
9.2.1 Latin America Stem Cell Therapy Market Size by Type (2017-2022)
9.2.2 Latin America Stem Cell Therapy Market Size by Type (2023-2028)
9.2.3 Latin America Stem Cell Therapy Market Share by Type (2017-2028)
9.3 Latin America Stem Cell Therapy Market Size by Application
9.3.1 Latin America Stem Cell Therapy Market Size by Application (2017-2022)
9.3.2 Latin America Stem Cell Therapy Market Size by Application (2023-2028)
9.3.3 Latin America Stem Cell Therapy Market Share by Application (2017-2028)
9.4 Latin America Stem Cell Therapy Market Size by Country
9.4.1 Latin America Stem Cell Therapy Market Size by Country (2017-2022)
9.4.2 Latin America Stem Cell Therapy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Stem Cell Therapy Market Size (2017-2028)
10.2 Middle East & Africa Stem Cell Therapy Market Size by Type
10.2.1 Middle East & Africa Stem Cell Therapy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Stem Cell Therapy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Stem Cell Therapy Market Share by Type (2017-2028)
10.3 Middle East & Africa Stem Cell Therapy Market Size by Application
10.3.1 Middle East & Africa Stem Cell Therapy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Stem Cell Therapy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Stem Cell Therapy Market Share by Application (2017-2028)
10.4 Middle East & Africa Stem Cell Therapy Market Size by Country
10.4.1 Middle East & Africa Stem Cell Therapy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Stem Cell Therapy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Osiris Therapeutics
11.1.1 Osiris Therapeutics Company Details
11.1.2 Osiris Therapeutics Business Overview
11.1.3 Osiris Therapeutics Stem Cell Therapy Introduction
11.1.4 Osiris Therapeutics Revenue in Stem Cell Therapy Business (2017-2022)
11.1.5 Osiris Therapeutics Recent Developments
11.2 NuVasive
11.2.1 NuVasive Company Details
11.2.2 NuVasive Business Overview
11.2.3 NuVasive Stem Cell Therapy Introduction
11.2.4 NuVasive Revenue in Stem Cell Therapy Business (2017-2022)
11.2.5 NuVasive Recent Developments
11.3 Chiesi Pharmaceuticals
11.3.1 Chiesi Pharmaceuticals Company Details
11.3.2 Chiesi Pharmaceuticals Business Overview
11.3.3 Chiesi Pharmaceuticals Stem Cell Therapy Introduction
11.3.4 Chiesi Pharmaceuticals Revenue in Stem Cell Therapy Business (2017-2022)
11.3.5 Chiesi Pharmaceuticals Recent Developments
11.4 JCR Pharmaceutical
11.4.1 JCR Pharmaceutical Company Details
11.4.2 JCR Pharmaceutical Business Overview
11.4.3 JCR Pharmaceutical Stem Cell Therapy Introduction
11.4.4 JCR Pharmaceutical Revenue in Stem Cell Therapy Business (2017-2022)
11.4.5 JCR Pharmaceutical Recent Developments
11.5 Pharmicell
11.5.1 Pharmicell Company Details
11.5.2 Pharmicell Business Overview
11.5.3 Pharmicell Stem Cell Therapy Introduction
11.5.4 Pharmicell Revenue in Stem Cell Therapy Business (2017-2022)
11.5.5 Pharmicell Recent Developments
11.6 Medi-post
11.6.1 Medi-post Company Details
11.6.2 Medi-post Business Overview
11.6.3 Medi-post Stem Cell Therapy Introduction
11.6.4 Medi-post Revenue in Stem Cell Therapy Business (2017-2022)
11.6.5 Medi-post Recent Developments
11.7 Anterogen
11.7.1 Anterogen Company Details
11.7.2 Anterogen Business Overview
11.7.3 Anterogen Stem Cell Therapy Introduction
11.7.4 Anterogen Revenue in Stem Cell Therapy Business (2017-2022)
11.7.5 Anterogen Recent Developments
11.8 Molmed
11.8.1 Molmed Company Details
11.8.2 Molmed Business Overview
11.8.3 Molmed Stem Cell Therapy Introduction
11.8.4 Molmed Revenue in Stem Cell Therapy Business (2017-2022)
11.8.5 Molmed Recent Developments
11.9 Takeda (TiGenix)
11.9.1 Takeda (TiGenix) Company Details
11.9.2 Takeda (TiGenix) Business Overview
11.9.3 Takeda (TiGenix) Stem Cell Therapy Introduction
11.9.4 Takeda (TiGenix) Revenue in Stem Cell Therapy Business (2017-2022)
11.9.5 Takeda (TiGenix) Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Stem Cell Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Autologous
Table 3. Key Players of Allogeneic
Table 4. Global Stem Cell Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Stem Cell Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Stem Cell Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Stem Cell Therapy Market Share by Region (2017-2022)
Table 8. Global Stem Cell Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Stem Cell Therapy Market Share by Region (2023-2028)
Table 10. Stem Cell Therapy Market Trends
Table 11. Stem Cell Therapy Market Drivers
Table 12. Stem Cell Therapy Market Challenges
Table 13. Stem Cell Therapy Market Restraints
Table 14. Global Stem Cell Therapy Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Stem Cell Therapy Revenue Share by Players (2017-2022)
Table 16. Global Top Stem Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cell Therapy as of 2021)
Table 17. Ranking of Global Top Stem Cell Therapy Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Stem Cell Therapy Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Stem Cell Therapy Product Solution and Service
Table 21. Date of Enter into Stem Cell Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Stem Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Stem Cell Therapy Revenue Market Share by Type (2017-2022)
Table 25. Global Stem Cell Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Stem Cell Therapy Revenue Market Share by Type (2023-2028)
Table 27. Global Stem Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Stem Cell Therapy Revenue Share by Application (2017-2022)
Table 29. Global Stem Cell Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Stem Cell Therapy Revenue Share by Application (2023-2028)
Table 31. North America Stem Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Stem Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Stem Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Stem Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Stem Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Stem Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Stem Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Stem Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Stem Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Stem Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Stem Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Stem Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Stem Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Stem Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Stem Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Stem Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Stem Cell Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Stem Cell Therapy Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Stem Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Stem Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Stem Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Stem Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Stem Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Stem Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Stem Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Stem Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Stem Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Stem Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Stem Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Stem Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 61. Osiris Therapeutics Company Details
Table 62. Osiris Therapeutics Business Overview
Table 63. Osiris Therapeutics Stem Cell Therapy Product
Table 64. Osiris Therapeutics Revenue in Stem Cell Therapy Business (2017-2022) & (US$ Million)
Table 65. Osiris Therapeutics Recent Developments
Table 66. NuVasive Company Details
Table 67. NuVasive Business Overview
Table 68. NuVasive Stem Cell Therapy Product
Table 69. NuVasive Revenue in Stem Cell Therapy Business (2017-2022) & (US$ Million)
Table 70. NuVasive Recent Developments
Table 71. Chiesi Pharmaceuticals Company Details
Table 72. Chiesi Pharmaceuticals Business Overview
Table 73. Chiesi Pharmaceuticals Stem Cell Therapy Product
Table 74. Chiesi Pharmaceuticals Revenue in Stem Cell Therapy Business (2017-2022) & (US$ Million)
Table 75. Chiesi Pharmaceuticals Recent Developments
Table 76. JCR Pharmaceutical Company Details
Table 77. JCR Pharmaceutical Business Overview
Table 78. JCR Pharmaceutical Stem Cell Therapy Product
Table 79. JCR Pharmaceutical Revenue in Stem Cell Therapy Business (2017-2022) & (US$ Million)
Table 80. JCR Pharmaceutical Recent Developments
Table 81. Pharmicell Company Details
Table 82. Pharmicell Business Overview
Table 83. Pharmicell Stem Cell Therapy Product
Table 84. Pharmicell Revenue in Stem Cell Therapy Business (2017-2022) & (US$ Million)
Table 85. Pharmicell Recent Developments
Table 86. Medi-post Company Details
Table 87. Medi-post Business Overview
Table 88. Medi-post Stem Cell Therapy Product
Table 89. Medi-post Revenue in Stem Cell Therapy Business (2017-2022) & (US$ Million)
Table 90. Medi-post Recent Developments
Table 91. Anterogen Company Details
Table 92. Anterogen Business Overview
Table 93. Anterogen Stem Cell Therapy Product
Table 94. Anterogen Revenue in Stem Cell Therapy Business (2017-2022) & (US$ Million)
Table 95. Anterogen Recent Developments
Table 96. Molmed Company Details
Table 97. Molmed Business Overview
Table 98. Molmed Stem Cell Therapy Product
Table 99. Molmed Revenue in Stem Cell Therapy Business (2017-2022) & (US$ Million)
Table 100. Molmed Recent Developments
Table 101. Takeda (TiGenix) Company Details
Table 102. Takeda (TiGenix) Business Overview
Table 103. Takeda (TiGenix) Stem Cell Therapy Product
Table 104. Takeda (TiGenix) Revenue in Stem Cell Therapy Business (2017-2022) & (US$ Million)
Table 105. Takeda (TiGenix) Recent Developments
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Stem Cell Therapy Market Share by Type: 2021 VS 2028
Figure 2. Autologous Features
Figure 3. Allogeneic Features
Figure 4. Global Stem Cell Therapy Market Share by Application: 2021 VS 2028
Figure 5. Musculoskeletal Disorder Case Studies
Figure 6. Wounds & Injuries Case Studies
Figure 7. Cornea Case Studies
Figure 8. Cardiovascular Diseases Case Studies
Figure 9. Others Case Studies
Figure 10. Stem Cell Therapy Report Years Considered
Figure 11. Global Stem Cell Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Stem Cell Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Stem Cell Therapy Market Share by Region: 2021 VS 2028
Figure 14. Global Stem Cell Therapy Market Share by Players in 2021
Figure 15. Global Top Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cell Therapy as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Stem Cell Therapy Revenue in 2021
Figure 17. North America Stem Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Stem Cell Therapy Market Size Market Share by Type (2017-2028)
Figure 19. North America Stem Cell Therapy Market Size Market Share by Application (2017-2028)
Figure 20. North America Stem Cell Therapy Market Size Share by Country (2017-2028)
Figure 21. United States Stem Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Stem Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Stem Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Stem Cell Therapy Market Size Market Share by Type (2017-2028)
Figure 25. Europe Stem Cell Therapy Market Size Market Share by Application (2017-2028)
Figure 26. Europe Stem Cell Therapy Market Size Share by Country (2017-2028)
Figure 27. Germany Stem Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Stem Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Stem Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Stem Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Stem Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Stem Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Stem Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Stem Cell Therapy Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Stem Cell Therapy Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Stem Cell Therapy Market Size Share by Region (2017-2028)
Figure 37. China Stem Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Stem Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Stem Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Stem Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Stem Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Stem Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Latin America Stem Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Stem Cell Therapy Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Stem Cell Therapy Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Stem Cell Therapy Market Size Share by Country (2017-2028)
Figure 47. Mexico Stem Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Stem Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Stem Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Stem Cell Therapy Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Stem Cell Therapy Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Stem Cell Therapy Market Size Share by Country (2017-2028)
Figure 53. Turkey Stem Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Stem Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Stem Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Osiris Therapeutics Revenue Growth Rate in Stem Cell Therapy Business (2017-2022)
Figure 57. NuVasive Revenue Growth Rate in Stem Cell Therapy Business (2017-2022)
Figure 58. Chiesi Pharmaceuticals Revenue Growth Rate in Stem Cell Therapy Business (2017-2022)
Figure 59. JCR Pharmaceutical Revenue Growth Rate in Stem Cell Therapy Business (2017-2022)
Figure 60. Pharmicell Revenue Growth Rate in Stem Cell Therapy Business (2017-2022)
Figure 61. Medi-post Revenue Growth Rate in Stem Cell Therapy Business (2017-2022)
Figure 62. Anterogen Revenue Growth Rate in Stem Cell Therapy Business (2017-2022)
Figure 63. Molmed Revenue Growth Rate in Stem Cell Therapy Business (2017-2022)
Figure 64. Takeda (TiGenix) Revenue Growth Rate in Stem Cell Therapy Business (2017-2022)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed